Hudson Bay Capital Management
NAUT icon

Hudson Bay Capital Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Hudson Bay Capital Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$115K Buy
29,594
+10,532
+55% +$25.9K ﹤0.01% 1165
2025
Q4 		$37.2K Buy
+19,062
New +$31.3K ﹤0.01% 1103
2020
Q4 		– Sell
-100,000
Closed -$1.07M – 663
2020
Q3 		$1.07M Buy
+100,000
New +$1.07M 0.02% 415

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Hudson Bay Capital Management's NAUT Position: Q1 2026 in Review

Hudson Bay Capital Management increased its Nautilus Biotechnolgy (NAUT) stake by 55% in Q1 2026, buying an estimated $25.9K and bringing the position to 29,594 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #1165.

Hudson Bay Capital Management first reported a position in NAUT in Q3 2020 and has held it in 3 quarters since. The position peaked at $1.07M in Q3 2020. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Hudson Bay Capital Management held 29,594 shares of Nautilus Biotechnolgy worth $115K as of Q1 2026.
  • Hudson Bay Capital Management bought 10,532 Nautilus Biotechnolgy shares in Q1 2026, an estimated $25.9K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #1165 holding.
  • Hudson Bay Capital Management first reported a position in Nautilus Biotechnolgy in Q3 2020 and has held it in 3 quarters since.
  • Hudson Bay Capital Management's Nautilus Biotechnolgy position peaked at $1.07M in Q3 2020.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.